Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
30 results
  1. NLM Digital Collections - Hospital and health administration index (Volume 54) 
    resource.nlm.nih.gov/9601831X4
    ... a case/non-case study in the French pharmacovigilance system database. Moore N, et al. Br J ... care professionals across the European Union. The European Pharmacovigilance Research Group. Belton KJ. Eur J Clin Pharmacol ...
  2. NLM Digital Collections - Hospital and health administration index (Volume 55) 
    resource.nlm.nih.gov/9601831X5
    ... reaction monitoring in Jena—experiences of a regionalized pharmacovigilance centre. Hoffmann A, et al. Exp Toxicol Pathol ... Oct; 89(10): 1567-70 Record-linkage for pharmacovigilance in Scotland. Evans JM, et al. Br J ...
  3. NLM Digital Collections - Hospital literature index (Volume 50) 
    resource.nlm.nih.gov/7807587X37
    ... 1015-22 Dealing with variability: the role of pharmacovigilance. Waller PC. J Pharm Pharmacol 1994 May; 46 ... Jan 1 ;51 (1 ):79-84 Harmonisation in pharmacovigilance. Edwards IR, et al. Drug Saf 1994 Feb; ...
  4. NLM Digital Collections - Long term follow-up after administration of human gene therapy products 
    Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, January 2020
    resource.nlm.nih.gov/101767662
    ... time of your BLA submission you submit a Pharmacovigilance Plan (PVP) as described in the FDA Guidance for Industry; E2E Pharmacovigilance Planning (Ref. 34). Of note, the ongoing or ...
  5. NLM Digital Collections - Hospital and health administration index (Volume 53) 
    resource.nlm.nih.gov/9601831X3
    ... in: BMJ 1997 Aug 30;315(7107):500. Pharmacovigilance in the 1990s [comment] Lawson DH. Br J ... 10 Drug-induced autoimmunity: experience of the French pharmacovigilance system. Vial T, et al. Toxicology 1997 Apr ...
  6. NLM Digital Collections - Pharmacological management of glycaemic control in people with type 2 diabetes : a national ... 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), November 2017
    resource.nlm.nih.gov/101730372
    ... SE, Bergenstal RM, Bakris 79 European Medicines Agency, Pharmacovigilance Risk Assessment GL, et al. Alogliptin after acute ... 35. Regulation (EC) No 726/2004 resulting from pharmacovigilance data - SGLT 2 inhibitors. London: European Medicines Agency; ...
  7. NLM Digital Collections - Considerations in demonstrating interchangeability with a reference product 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2019
    resource.nlm.nih.gov/101760108
    ... for an interchangeable product should also have adequate pharmacovigilance mechanisms in place.33 Rare but potentially serious ... the BPCI Act (December 2018). 33 For general pharmacovigilance considerations, see the guidance for industry Good Pharmacovigilance ...
  8. NLM Digital Collections - Hospital literature index (Volume 46) 
    resource.nlm.nih.gov/7807587X33
    ... Centre Hospitalier Intercommunal de Creteil, Centre Regional de Pharmacovigilance, France.): Current French system of post-marketing drug ... Schulz R Girard M (Groupe de Recherche en Pharmacovigilance, Paris, France.): Oral provocation: limitations. Semin Dermatol 1989 ...
  9. NLM Digital Collections - Hospital literature index (Volume 48) 
    resource.nlm.nih.gov/7807587X35
    ... Clin Epidemiol 1992 Mar;45(3):283-6 Pharmacovigilance. Griffin JP. J R Coll Physicians Lond 1992 ... JP (Association of the British Pharmaceutical Industry, London.): Pharmacovigilance. J R Coll Physicians Lond 1992 Apr;26( ...
  10. NLM Digital Collections - Human gene therapy for rare diseases 
    Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, January 2020
    resource.nlm.nih.gov/101767660
    ... be addressed early in product development (Ref. 14). • Pharmacovigilance systems should actively monitor each recipient of a ... 89036/download. 13 Contains Nonbinding Recommendations 15. E2E Pharmacovigilance Planning; Guidance for Industry, April 2005. https://www. ...
previous · 1 · 2 · 3 · next